Skip to main content

Table 1 Demographics of 12 patients with pancreatic adenosquamous carcinoma.

From: Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma

Case Age/sex Symptoms Comorbidity Laboratory data Tumor markers
     Hb
(g/dL)
Bil (T)
(mg/dL)
Alk-P
(U/L)
CEA (ng/mL) CA 19-9 (U/mL)
1 73/F Abd pain, BWL, jaundice HTN 10.4 15.7 258 262 240
2 66/M BWL, jaundice, anorexia DM 10.2 14.8 438 13.1 >240
3 65/F Abd pain, BWL, diarrhea HTN, heart disease 13.4 0.4 89 25.2 15.7
4 63/M Abd pain, BWL Peptic ulcer 13.2 0.5 92 10.2 135
5 78/M Abd pain, anorexia Nil 10.6 0.7 78 12.4 142.4
6 79/M Abd pain, BWL, anorexia, abd mass Nil 12.6 0.5 95 17.6 8.5
7 38/F Abd pain, BWL, jaundice DM 10.7 23.2 192 14.5 138
8 79/F Abd pain, dizziness, malaise HTN, DM, Peptic ulcer 7.0 0.8 59 2300 >240
9 76/F Abd pain, BWL HTN 11.3 0.5 93 5.34 129
10 32/M Abd pain, BWL Peptic ulcer 15.2 0.5 84 1.79 84
11 69/F Abd pain, BWL, anorexia DM 9.4 0.5 66 83.74 >240
12 78/F Abd pain, BWL, anorexia, malaise HTN 10.6 0.3 68 0.57 160.9
  1. Abd, abdominal; Alk-P, alkaline phosphatase; Bil (T): total bilirubin; BWL, body weight loss; CA19-9, carbohydrate antigen 19-9 (< 37 U/mL); CEA, carcinoembryonic antigen (< 5 ng/mL); DM, diabetes mellitus; Hb, hemoglobin; HTN, hypertension.